Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.


TSX:HLS - Post by User

Bullboard Posts
Post by amugsgameon Jun 20, 2013 10:04pm
430 Views
Post# 21552459

A Few More Questions

A Few More Questions

Despite claims here that Ï am looking to drive down the price to pick up cheap stocks or that I am presenting a "ludicrous short" theory, I can assure readers of this board that I am only looking for answers. You see I have learned on a few occasions that a companies financial statements and the reality of the stock can be two different things. Due diligence and a great dose of cynicism are an investors best friends 

So a few more questions about AM that are troubling me :

  • on a day like today when the market is hammered and auto / auto supplier stocks like Ford, Linamar, Magna are all down  AM did not budge. So where would AM be without the company keeping the stock price up with their soon ending buyback program
  • AM claims that it will have $6 mil in exit costs due to the closure of 2 plants but this does not seem to take into account that it also has $7 mil in lease obligations between 2014 / 2017 as stated in the March 2013 Interim Report - so what product will pay for the leases?
  • last Oct. AM's price dropped to $1.62 at a time when the company actually had potential to extend the Ford contract and diversify more into wind energy . Today, when the Ford contract is fading in the sunset and wind production shows no huge change ,  the stock is at $1.63 - does that make sense?   

Again these are just plain questions based on facts. As with my other post, I am happy to be corrected on anything I have got wrong But please do it with facts   

Bullboard Posts